Target intelligence / Profile preview

Exocyst complex component 8 (EXOC8)

Target
EXOC8
Molecular classification
Other (Subunit of the exocyst complex; not an enzyme, receptor, transporter, nor ion channel), Vesicular trafficking complex protein
01

Overview

Exocyst complex component 8 (EXOC8), also known as Exo84 or SEC84, is a core subunit of the octameric exocyst complex—a conserved multi-protein assembly essential for tethering post-Golgi vesicles to the plasma membrane, thus mediating vesicular trafficking and exocytosis. EXOC8 regulates the spatiotemporal delivery of cargo crucial for cell polarity, growth, and differentiation. Through direct interaction with small GTPases (e.g., RalA, RalB, and Rab10), EXOC8 integrates multiple signaling pathways linking membrane trafficking to autophagy, the secretory pathway, actin cytoskeleton remodeling, cell junction formation, targeted protein delivery (such as ciliary and neuronal proteins), and tumor cell invasion. Mutations in EXOC8 have been associated with human diseases including Joubert syndrome and neurodevelopmental disorders, while altered function or regulation contributes to cancer cell invasiveness and potentially metabolic disease. While no direct pharmacological inhibitors are currently in use, the multifunctional nature of EXOC8 within the exocyst suggests it is a fundamental node regulating cell physiology and disease progression, though clinical targeting may pose challenges due to its central mechanical roles

Other names
EXOC8EXO84SEC84Exo84pexocyst complex 84 kDa subunitNEDMISB
02

Mechanism of action

Not applicable / None established. No drugs are known to act on EXOC8’s mechanism directly.

03

Biological functions

Vesicular traffickingExocytosisSecretory pathwayCell polarity establishmentAutophagosome formationMetabolic regulation (e.g., insulin-stimulated GLUT4 vesicle docking)Invasion/metastasis (tumor cell invasion)Cell–cell junctions (formation/maturation of adherens and desmosomal junctions)Neurite outgrowthCiliary protein targeting
04

Disease associations

Neurodevelopmental disorders (including microcephaly, seizures, brain atrophy, and Joubert syndrome)Cancer (tumor cell invasion, oncogenic transformation)Potential roles in metabolic diseases (insulin action)Other (implicated in cellular homeostasis, polarity, and barriers)
05

Safety considerations

None specifically described. As a core vesicle trafficking component, systemic inhibition could disrupt essential cellular processes, raising concerns about broad toxicity if targeted directly.
06

Interacting drugs

None specifically documented
07

Biomarkers

None established

Beyond the preview

Go deeper on Exocyst complex component 8 (EXOC8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exocyst complex component 8 (EXOC8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call